Dexcom G6 Observational Study



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:2/24/2019
Start Date:February 21, 2019
End Date:February 2020
Contact:Guillermo Umpierrez, MD
Email:geumpie@emory.edu
Phone:404-778-1665

Use our guide to learn which trials are right for you!

Inpatient and Post-hospital Discharge Assessment of Glycemic Control by Capillary Point-of-care Glucose Testing and by Continuous Glucose Monitoring in Insulin-treated Patients With Type 1 and Type 2 Diabetes: Dexcom G6 Observational Study

This is an exploratory prospective study primary aiming to evaluate differences between
Point-of-care (POC) testing (standard of care) and Dexcom G6 CGM (Continues Glucose
Monitoring sensor system) in 1) glycemic control measured by mean daily blood glucose and 2)
identifying hypoglycemic and hyperglycemic events - in patients with type 1 and type 2
diabetes treated with basal bolus insulin regimen.

Several studies have shown that the use of a device that can measure blood glucose levels
every 5 minutes is more effective in identifying low blood glucose (hypoglycemia) and high
blood glucose (hyperglycemia) when compared to regular measurements with fingersticks [point
of care (POC)].

This is an exploratory prospective study primary aiming to evaluate differences between
Point-of-care (POC) testing (standard of care) and Dexcom G6 CGM (Continues Glucose
Monitoring sensor system) in 1) glycemic control measured by mean daily blood glucose and 2)
identifying hypoglycemic and hyperglycemic events - in patients with type 1 and type 2
diabetes treated with basal bolus insulin regimen.

Inclusion Criteria:

1. > 18 years admitted to a general medicine or surgical service.

2. Known history of T1D or T2D receiving insulin therapy

3. Subjects must have a randomization BG between 140 mg and 400 mg/dL without laboratory
evidence of diabetic ketoacidosis (bicarbonate < 18 mEq/L, pH < 7.30, or positive
serum or urinary ketones).

4. Patients with expected hospital length-of-stay of 3 or more days

Exclusion Criteria:

1. Patients with acute illness admitted to the ICU or expected to require admission to
the ICU.

2. Patients expected to require MRI procedures during hospitalization.

3. Mental condition rendering the subject unable to understand the nature, scope, and
possible consequences of the study.

4. Female subjects who are pregnant or breast‑feeding at time of enrollment into the
study.
We found this trial at
1
site
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Principal Investigator: Guillermo Umpierrez, MD
Phone: 404-778-1665
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials